This study investigates the efficacy and safety of an investigational medication compared to a placebo in patients who have undergone a bilateral lung transplant and have chronic lung allograft dysfunction (CLAD). CLAD is a condition where the lung function declines over time after a transplant. Participants must be at least …
This study investigates airway inflammation in individuals aged 40 to 85 years with Chronic Obstructive Pulmonary Disease (COPD). COPD is a lung condition that makes it hard to breathe due to narrowed airways. The purpose is to compare the effects of an investigational medication given as an injection under the …
This study investigates the efficacy, safety, and tolerability of an investigational medication given as a subcutaneous injection compared to a placebo in adults with chronic obstructive pulmonary disease (COPD). COPD is a long-term lung disease that causes breathing difficulties. This study focuses on participants who have an eosinophilic phenotype, which …
This study investigates the effects of an investigational medication, administered subcutaneously, in adults with Chronic Obstructive Pulmonary Disease (COPD) characterized by an eosinophilic phenotype. COPD is a chronic lung disease that causes breathing difficulties and is often associated with long-term exposure to harmful substances like cigarette smoke. The study aims …
This study investigates the long-term safety and effects of an investigational medication in adults with Alpha-1 Antitrypsin Deficiency (AATD) emphysema. AATD is a genetic condition that can lead to lung diseases like emphysema. Emphysema is a lung condition that causes shortness of breath due to damaged air sacs in the …
This study investigates the effect of an investigational medication compared to standard care in preventing or slowing the decline of lung function in adults with uncontrolled moderate to severe asthma. Asthma is a condition where the airways in the lungs become inflamed and narrow, making it hard to breathe. The …
This study investigates the effects of investigational medications compared to a placebo on lung capacity in people with Interstitial Lung Disease (ILD) caused by Systemic Sclerosis (SSc). Systemic Sclerosis is a condition where the skin and other organs become hard and thick due to increased collagen. The study aims to …
